Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.
Poprach A, Kiss I, Stanik M, Barusova T, Pospisilova L, Fiala O, Kopecky J, Richter I, Melichar B, Studentova H, Lakomy R, Holanek M, Rozsypalova A, Zemanková A, Svoboda M, Buchler T.
Poprach A, et al. Among authors: rozsypalova a.
Target Oncol. 2023 Nov;18(6):893-903. doi: 10.1007/s11523-023-01013-0. Epub 2023 Nov 13.
Target Oncol. 2023.
PMID: 37957520